Efficacy and Safety Study of Darolutamide (ODM-201) in Men With High-risk Non-metastatic Castration-resistant Prostate Cancer

Clinical trial NCT02200614 · COMPLETED

Trial details

NCT number: NCT02200614
Sponsor: Bayer
Status: COMPLETED
Phase: Phase 3
Study type: INTERVENTIONAL

Prostate Cancer Non-Metastatic Castration-Resistant

Start date: 2014-09-12
Primary completion: 2018-09-03
Enrollment: 1509

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.